Quidel Announces FDA Clearance Of Its RapidVue(R) HCG Pregnancy Lateral Flow Diagnostic Test

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of Quidel's RapidVue® hCG test, a lateral flow pregnancy immunoassay for the qualitative detection of human Chorionic Gonadotropin (hCG)...